NDC product
Aurovisc OE
NDC 16030-304 · Aurolab
Key facts
| Product NDC | 16030-304 |
|---|---|
| Proprietary name | Aurovisc OE |
| Nonproprietary name | Hypromellose Ophthalmic Solution 2% w/v |
| Substances | HYPROMELLOSE 2208 (15000 MPA.S) |
| Dosage form | SOLUTION |
| Route | OPHTHALMIC |
| Labeler | Aurolab |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M018 |
| Marketing start | Apr 1, 2025 |
| Marketing end | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory